Medhi Denisa Alinda

Medhi Denisa Alinda

Auto-generated profile, based on publicly available information

Medhi Denisa Alinda

Department of Dermatology, Venereology, Aesthetics, Faculty of Medicine, Airlangga University, Surabaya, Indonesia

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 June 2022 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
APAnnisa Ika Putri
Annisa Ika Putri
KSKevin de Sabbata
Kevin de Sabbata
RARegitta I. Agusni
Regitta I. Agusni
MAMedhi Denisa Alinda
Medhi Denisa Alinda
JDJoydeepa Darlong
Joydeepa Darlong
RPRuth M. H. Peters
Ruth M. H. Peters
Background: Leprosy reactions, Type-1 and erythema nodosum leprosum, are immune-mediated complications of leprosy, which play a significant role in the morbidity associated with the disease. A considerable amount of literature has been published on the impact of leprosy in general but few studies focus specifically on leprosy reactions. This study aimed to investigate the impact of leprosy reactions on physical, psychological, and social aspects of the lives of people affected by analysing their life experiences and perspectives about leprosy reactions.Methods/Principal findings: This qualitative study involved people affected by leprosy reactions and their family members in two leprosy endemic countries. The data were collected through 66 interviews and 9 focus group discussions (4–6 participants each) in Surabaya, Indonesia, and Purulia, India. Content analysis and conversational analysis were performed. This study found that both types of leprosy reactions were perceived as an unpredictable and painful condition. Leprosy reactions restricted physical activities of the participants, such as going to bathroom, sleeping, eating, and cooking. In the interviews, the respondents expressed a range of emotions and feelings including confusion, sadness, anxiety, and anger. Some recounted that they felt stigmatized and lost opportunities to socialise and earn money. Differences between the two settings were identified. The majority of Indonesian participants preferred to stay at home, and some concealed the diagnosis of leprosy, while most of the Indian respondents continued working up to the time of hospitalization.Conclusion: Leprosy reactions are a distressing complication of leprosy and adversely affect the lives of those affected. Individuals reported physical discomfort, distress, anxiety, stigma, and financial hardship and these negative impacts in the physical, psychological, and social spheres reinforced each other. These findings provide important information about a need for early detection and sustained commitment to follow-up care for people with a history of leprosy reactions. More research on new drugs for reactional episodes, tools to measure knowledge, attitude, and practice, and costing study on leprosy reactions treatment are needed. We recommend the development and testing of holistic strategies to improve the management of leprosy reactions.

7 December 2022 in Indian Journal of Dermatology, Venereology and Leprology
Verified
Journal Article
Open access
MAMedhi Denisa Alinda
Medhi Denisa Alinda
PCPaulus Mario Christopher
Paulus Mario Christopher
MLMuhammad Yulianto Listiawan
Muhammad Yulianto Listiawan
AEAnang Endaryanto
Anang Endaryanto
HSHeri Suroto
Heri Suroto
CPCita Rosita Sigit Prakoeswa
Cita Rosita Sigit Prakoeswa
Background: Wound healing shows a unique interaction of several cells, growth factors and cytokines. The healing of chronic plantar ulcer of leprosy is influenced by various factors, one of which is the concentration of growth factors and cytokines related to the pathogenesis of impaired wound healing. Growth factors and cytokines can be found in the secretome of adipose mesenchymal stem cells. Aim: To compare the effectiveness of topical adipose mesenchymal stem cell-conditioned medium and framycetin gauze dressing only on the healing of chronic plantar ulcer of leprosy. Methods: In this randomised controlled trial, 32 patients with chronic plantar ulcer of leprosy were recruited. After detailed clinical and initial debridement, patients were randomised to two groups to receive either topical adipose mesenchymal stem cell-conditioned medium (n = 16) or framycetin gauze dressing only (n = 16) applied every three days for up to eight weeks, following which the ulcer size, adverse reactions and complications if any were monitored weekly. Results: Healing percentage increased each week in all groups. Statistical differences between groups (P < 0.05) were observed from week 2 onwards for ulcer mean size reduction and from week 3 onwards for ulcer mean depth reduction. There were no adverse reactions or complications. Limitations: Off-loading on subjects were not performed. Conclusion: Adipose mesenchymal stem cell-conditioned medium is a potential therapeutic agent in the management of chronic plantar ulcer of leprosy.

2 June 2021 in Transactions of the Royal Society of Tropical Medicine and Hygiene
Verified
Journal Article
Open access
PDF file
BBBarbara de Barros
Barbara de Barros
SLSaba M Lambert
Saba M Lambert
ENEdessa Negera
Edessa Negera
GAGuillermo Robert de Arquer
Guillermo Robert de Arquer
ASAnna M Sales
Anna M Sales
SWStephen L Walker
Stephen L Walker
The coronavirus disease 2019 (COVID-19) pandemic has led to governments implementing a variety of public health measures to control transmission and has affected health services. Leprosy is a communicable neglected tropical disease caused by Mycobacterium leprae and is an important health problem in low- and middle-income countries. The natural history of leprosy means that affected individuals need long-term follow-up. The measures recommended to reduce transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can create barriers to health services. We evaluated the impact of the COVID-19 epidemic response on leprosy services and disease management. We conducted a cross-sectional online survey with healthcare professionals in leprosy referral centres. Eighty percent of leprosy diagnostic services were reduced. All respondents reported that multidrug therapy (MDT) was available but two reported a reduced stock. Clinicians used alternative strategies such as telephone consultations to maintain contact with patients. However, patients were not able to travel to the referral centres. This study highlights the effects of the initial phase of the SARS-CoV-2 pandemic on leprosy services in a range of leprosy-endemic countries. Many services remained open, providing leprosy diagnosis, MDT and leprosy reaction medications. Centres developed innovative measures to counter the negative impacts of the COVID-19 pandemic.

31 July 2020 in Berkala Ilmu Kesehatan Kulit dan Kelamin
Verified
Journal Article
Open access
PDF file
MAMedhi Denisa Alinda
Medhi Denisa Alinda
SGSilvani Geani
Silvani Geani
RARegitta Indira Agusni
Regitta Indira Agusni
BKBagus Haryo Kusumaputra
Bagus Haryo Kusumaputra
NRNovianti Rizky Reza
Novianti Rizky Reza
MLMuhammad Yulianto Listiawan
Muhammad Yulianto Listiawan
Background: Leprosy is a chronic infectious disease caused by Mycobacterium leprae, which tends to attack peripheral nerves and skin. The diagnosis of leprosy is based on the presence of one of three cardinal signs. Early diagnosis of leprosy is critical and is made through clinical examination and investigation. Purpose: To discuss the diagnosis, laboratory examination, and treatment of leprosy, considering that early diagnosis and appropriate treatment are the key elements in breaking the chain of transmission and preventing leprosy patients' disabilities. Review: Leprosy is a chronic granulomatous infectious disease caused by the Mycobacterium leprae. Based on clinical appearance, histopathology findings, and immunological, leprosy is grouped into six forms using the Ridley-Jopling classification, namely Tuberculoid (TT), Borderline Tuberculoid (BT), Borderline-borderline Mid-borderline (BB), Borderline-lepromatous (BL), Subpolar Lepromatous (LLs), and Polar Lepromatous (LLp). Based on the treatment category, leprosy is grouped into paucibacillary (PB) and multibacillary (MB). Leprosy is often diagnosed clinically, and skin scraping smear remains the preferred laboratory method. The negative results of smear skin scraping may not necessarily exclude leprosy. Therefore, a higher sensitivity test might be needed to detect M. leprae. Treatment with Multi-Drug Therapy (MDT) is adjusted based on the type of leprosy, whether it belongs to the PB or MB group. Treatment of PB type, regimens are rifampicin and dapsone, while in MB type, the patients received rifampicin, dapsone, and clofazimine regimens. Conclusion: A proper diagnosis for leprosy, both through physical examination and laboratory examination, is required to determine an effective MDT treatment and break the chain of disease transmission.

14 September 2021 in Bali Medical Journal
Verified
Journal Article
Open access
MAMedhi Denisa Alinda
Medhi Denisa Alinda
PCPaulus Mario Christopher
Paulus Mario Christopher
MLMuhammad Yulianto Listiawan
Muhammad Yulianto Listiawan
AEAnang Endaryanto
Anang Endaryanto
HSHeri Suroto
Heri Suroto
CPCita Rosita Sigit Prakoeswa
Cita Rosita Sigit Prakoeswa
Introduction: Chronic Plantar Ulcer of Leprosy (CPUL), one of the debilitating disabilities and complications, poses a treatment challenge. Utilization of stem cells, specifically adipocyte-derived mesenchymal stem cells-conditioned medium (ADMSC-CM) and amniotic membrane mesenchymal stem cells-conditioned medium (AMSC-CM), may serve as a novel therapeutic option. This study aims to compare the efficacy of topical ADMSC-CM, topical AMSC-CM, and farmazertin gauze dressing (FGD) only on the healing of CPUL.Methods: In this randomized controlled trial, our study recruited 54 subjects with CPUL. Subjects were randomly assigned to topical ADMSC-CM (n = 16), topical AMSC-CM (n = 22), or FGD (n = 16) applied every three days for up to 8 weeks. Data were analyzed using SPSS version 20 for Windows.Results: Healing percentage increased each week in all groups. Statistic differences between groups (p <0.05) were observed for ulcer mean size and depth reduction from week three onwards. No adverse reactions or complications were reported. At the end of the study, based on clinically improved ulcers, topical ADMSC-CM (100.0%) were superior in improving the healing of CPULs compared to topical AMSC-CM (54.55%) and FGD only (50.0%).Conclusion: ADMSC-CM and AMSC-CM are potential therapeutic agents in the management of CPUL, with ADMSC-CM being superior in overall ulcer improvement.

31 October 2026 in World Journal of Advanced Research and Reviews
Verified
Journal Article
Open access
NMNaila Mafazah
Naila Mafazah
SASylvia Anggraeni
Sylvia Anggraeni
DNDewi Nurasrifah
Dewi Nurasrifah
DDDamayanti Damayanti
Damayanti Damayanti
YWYuri Widya
Yuri Widya
AHAfif Nurul Hidayati
Afif Nurul Hidayati
Drug-induced acneiform eruptions have been well-known side effects of systemic corticosteroids, usually presenting as monomorphic inflamed papules and pustules without comedones. Similar to Malassezia folliculitis, their presentation can make their diagnosis difficult especially among teenagers taking systemic corticosteroids for long periods of time.A 14-year-old boy presented with progressive papulopustular lesions that first affected his back after approximately two months of therapy with oral methylprednisolone for traumatic optic nerve edema. In total, there were numerous discrete, monomorphic, and predominantly folliculocentric red papules and pustules involving his face, neck, chest, shoulders, back, and proximal upper limbs. No comedones, nodules, and cysts were present, and he experienced minimal pruritus. In spite of the morphology and distribution being suggestive of Malassezia folliculitis, the direct examination under potassium hydroxide preparation of lesional material showed no yeast or hyphal forms. Based on the temporal relationship with high doses of methylprednisolone, morphology, minimal pruritus, negative direct microscopy, and lack of an alternate well-established etiology, a steroid-induced acneiform eruption was diagnosed. Methylprednisolone was decreased based on an ophthalmologist-directed taper regimen, along with oral erythromycin, cetirizine, and topical fusidic acid. After one week of treatment, pain, purulent drainage, and inflammation were improved without development of new lesions. With a Naranjo score of 6, it was probable. Systemic corticosteroid-induced acneiform eruption needs to be taken into account in cases where the patient is suffering from a monomorphic papulopustular eruption while on treatment. Since there is an extensive similarity in both the diseases with respect to the clinical presentation, diagnosis can only be done by considering all aspects together.